Yvonne Maldonado
Academic Appointments
- Professor, Pediatrics - Infectious Diseases
- Member, Child Health Research Institute
- Professor, Health Research & Policy
Key Documents
Contact Information
-
Clinical Offices
Pediatric Infectious Disease 730 Welch Rd 2nd Floor MC 5884 Palo Alto, CA 94304 Tel Work (650) 721-5805 Fax (650) 725-8040Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Tel (650) 723-5682Alternate Contact Nancy Wilkening Administrative Assistant Email Tel Work 650-498-6277Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Infectious Diseases, Pediatric
- Pediatric Infectious Disease
Administrative Appointments
- Medical Director, Infection Control, LPCH (2006 - present)
Professional Education
| Fellowship: | Centers for Disease Control and Prevention GA (1988) |
| Fellowship: | John Hopkins Hospital MD (1986) |
| Residency: | John Hopkins Hospital MD (1984) |
| Board Certification: | General Pediatrics, American Board of Pediatrics (1986) |
| Internship: | Stanford University School of Medicine CA (1982) |
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
The research I have conducted has been focused on epidemiologic aspects of viral vaccine development and prevention of perinatal HIV transmission. A major project has been to identify the molecular epidemiology of factors affecting the immunogenicity of oral polio vaccine (OPV) among children living in developing areas of the world, where OPV immunogenicity is poor. We have identified several factors which affect the poor immunogenicity of OPV and will conduct clinical studies to attempt to improve immunogenicity. We are now working on ways to understand the transmission and circulation of polio vaccine derived viruses, which may cause polio, and how to use this information in global eradication of polio. I also work on perinatal HIV infection, including strategies to prevent breastfeeding transmission in developing settings as well as understanding how to maximize prevention strategies among pregnant women in developed countries.
A second recent project has been to define the ontogeny of the immune response to measles vaccine among young infants. The purpose is to identify specific humoral and cell-mediated immune responses to measles vaccine which affect vaccine immunogenicity and induce the immunosuppressive effects associated with measles vaccination.
A final project I have conducted since 1989 involves a long term natural history study of infants with perinatal HIV exposure and infection. This computer-based study involves following all HIV-exposed and infected infants living in the Northern California and defining factors associated with progression of HIV-related disease.
Clinical Trials
Publications
- Hematologic and immunologic parameters in zimbabwean infants: a case for using local reference intervals to monitor toxicities in clinical trials. J Trop Pediatr. 2012; (1): 59-62
- Intradermal fractional dose inactivated polio vaccine: a review of the literature. Vaccine. 2012; (2): 121-5
- Timing of antiretroviral therapy initiation and its impact on disease progression in perinatal human immunodeficiency virus-1 infection. Pediatr Infect Dis J. 2012; (1): 53-60
- Barriers to care and current medical and social needs of HIV-positive patients in Albania. Cent Eur J Public Health. 2011; (2): 91-7
- Epidemiologic trends in penile anomalies and hypospadias in the state of California, 1985-2006. J Pediatr Urol. 2011; (3): 294-8

